| Should charge variants of monoclonal antibody therapeutics be considered critical quality attributes? SK Singh, G Narula, AS Rathore Electrophoresis, 2016 | 55 | 2016 |
| Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis AS Rathore, SK Singh, M Pathak, EK Read, CD Agarabi, M Khan, ... Biotechnology Progress 31 (6), 1586-1599, 2015 | 46 | 2015 |
| Assessing analytical comparability of biosimilars: GCSF as a case study N Nupur, SK Singh, G Narula, AS Rathore Journal of Chromatography B 1032, 165-171, 2016 | 33 | 2016 |
| Use of multivariate data analysis in bioprocessing A Rathore, S Singh BioPharm Int 28 (6), 26-31, 2015 | 26* | 2015 |
| LC–MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity SK Singh, D Kumar, H Malani, AS Rathore Scientific reports 11 (1), 2487, 2021 | 20 | 2021 |
| Understanding the mechanism of copurification of “difficult to remove” host cell proteins in rituximab biosimilar products SK Singh, A Mishra, D Yadav, N Budholiya, AS Rathore Biotechnology progress 36 (2), e2936, 2020 | 20 | 2020 |
| Determination of critical quality attributes for a biotherapeutic in the QbD paradigm: GCSF as a case study SK Singh, D Kumar, AS Rathore The AAPS Journal 19, 1826-1841, 2017 | 15 | 2017 |
| Glycosylation in mAb therapeutic products: analytical characterization and impact of process I Krull, G Narula, V Hebbi, SK Singh, A Rathore MJH Life Sciences 34, 34–46-34–46, 2016 | 11 | 2016 |
| Production of Protein Therapeutics in the Quality by Design (QbD) Paradigm AS Rathore, SK Singh Topics in medicinal chemistry, 2016 | 7 | 2016 |
| Bioprocessing of recombinant proteins from Escherichia coli inclusion bodies: insights from structure-function relationship for novel applications K Kachhawaha, S Singh, K Joshi, P Nain, SK Singh Preparative Biochemistry & Biotechnology 53 (7), 728-752, 2023 | 6 | 2023 |
| Engineered biosensors for diagnosing multidrug resistance in microbial and malignant cells NG Jha, DS Dkhar, SK Singh, SJ Malode, NP Shetti, P Chandra Biosensors 13 (2), 235, 2023 | 6 | 2023 |
| Practical Considerations of Capillary Electrophoresis–Mass Spectrometry for Analysis of Biotherapeutics SK Singh, V Hebbi, AS Rathore, IS Krull | 6* | 2016 |
| Assessment of Functional Characterization and Comparability of Biotherapeutics: a Review R Dash, SK Singh, N Chirmule, AS Rathore The AAPS Journal, 2021 | 5 | 2021 |
| Characterization of monoclonal antibody glycan heterogeneity using hydrophilic interaction liquid chromatography-mass spectrometry SK Singh, KH Lee Frontiers in Bioengineering and Biotechnology, 2021 | 5 | 2021 |
| Implementation of QbD for Manufacturing of Biologics—Has It Met the Expectations? AS Rathore, SK Singh, J Kumar, G Kapoor Biopharmaceutical Processing, 1051-1073, 2018 | 5 | 2018 |
| A charge variant of bevacizumab offers enhanced FcRn-dependent pharmacokinetic half-life and efficacy SK Singh, D Kumar, S Nagpal, SK Dubey, AS Rathore Pharmaceutical Research 39 (5), 851-865, 2022 | 4 | 2022 |
| Modulation of granulocyte colony stimulating factor conformation and receptor binding by methionine oxidation SK Singh, A Mishra, G Goel, N Chirmule, AS Rathore Proteins: Structure, Function, and Bioinformatics 89 (1), 68-80, 2021 | 3 | 2021 |
| Chemometrics applications in process chromatography AS Rathore, SK Singh Preparative chromatography for separation of proteins, 479-500, 2017 | 3 | 2017 |
| Computational approaches for development of engineered therapeutics against SARS-CoV-2 A Joshi, T Tripathi, SK Singh, AK Padhi Biochemistry 62 (3), 669-671, 2022 | 2 | 2022 |
| Creation of monoclonal antibody expressing CHO cell lines grown with sodium butyrate and characterization of resulting antibody glycosylation D Nmagu, SK Singh, KH Lee Methods in Enzymology, 2021 | 2 | 2021 |
Deepak KumarChemical Engineering, IIT DelhiVerified email at iitd.ac.in
